Literature DB >> 33280409

Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection.

Nicholas Yozamp1, Gregory L Hundemer2, Marwan Moussa3, Jonathan Underhill3, Tali Fudim3, Barry Sacks3, Anand Vaidya1.   

Abstract

Primary aldosteronism is an underdiagnosed cause of hypertension. Although inadequate screening is one reason for underdiagnosis, another important contributor is that clinicians may inappropriately exclude the diagnosis when screening aldosterone concentrations fall below traditionally established thresholds. We evaluated the intraindividual variability in screening aldosterone concentrations and aldosterone-to-renin ratios, and how this variability could impact case detection, among 51 patients with confirmed primary aldosteronism who had 2 or more screening measurements of renin and aldosterone on different days. There were a total of 137 screening measurements with a mean of 3 (range 2-6) per patient. The mean intraindividual variability, expressed as coefficients of variation, was 31% for aldosterone and 45% for the aldosterone-to-renin ratio. Aldosterone concentrations ranged from 4.9 to 51 ng/dL; 49% of patients had at least one aldosterone measurement below 15 ng/dL, 29% had at least 2 aldosterone measurements below 15 ng/dL, and 29% had at least one measurement below 10 ng/dL. Individual aldosterone-to-renin ratios ranged from 8.2 to 427 ng/dL per ng/mL·hour; 57% had at least one ratio below 30 ng/dL per ng/mL·hour, 27% had at least 2 ratios below 30 ng/dL per ng/mL·hour, and 24% had at least one ratio below 20 ng/dL per ng/mL·hour. Aldosterone concentrations and aldosterone-to-renin ratios are highly variable in patients with primary aldosteronism, with many screening values falling below conventionally accepted diagnostic thresholds. The diagnostic yield for primary aldosteronism may be substantially increased by recalibrating the definition of a positive screen to include more liberal thresholds for aldosterone and the aldosterone-to-renin ratio.

Entities:  

Keywords:  aldosterone; angiotensins; diagnosis; plasma; renin

Mesh:

Substances:

Year:  2020        PMID: 33280409      PMCID: PMC7878320          DOI: 10.1161/HYPERTENSIONAHA.120.16429

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  48 in total

1.  Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.

Authors:  Athina Markou; Amalia Sertedaki; Gregory Kaltsas; Ioannis I Androulakis; Chrisanthi Marakaki; Theodora Pappa; Aggeliki Gouli; Labrini Papanastasiou; Stelios Fountoulakis; Achilles Zacharoulis; Apostolos Karavidas; Despoina Ragkou; Evangelia Charmandari; George P Chrousos; George P Piaditis
Journal:  J Clin Endocrinol Metab       Date:  2015-05-14       Impact factor: 5.958

2.  Guidelines for primary aldosteronism: uptake by primary care physicians in Europe.

Authors:  Paolo Mulatero; Silvia Monticone; Jacopo Burrello; Franco Veglio; Tracy A Williams; John Funder
Journal:  J Hypertens       Date:  2016-11       Impact factor: 4.844

3.  Primary Aldosteronism: At the Tipping Point.

Authors:  John W Funder
Journal:  Ann Intern Med       Date:  2020-05-26       Impact factor: 25.391

4.  High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.

Authors:  Ermanno Rossi; Giuseppe Regolisti; Aurelio Negro; Carlo Sani; Simona Davoli; Franco Perazzoli
Journal:  Am J Hypertens       Date:  2002-10       Impact factor: 2.689

5.  Angiotensin-responsive aldosterone-producing adenomas: postoperative disappearance of aldosterone response to angiotensin.

Authors:  T J Tunny; S A Klemm; M Stowasser; R D Gordon
Journal:  Clin Exp Pharmacol Physiol       Date:  1993-05       Impact factor: 2.557

6.  Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.

Authors:  Athina Markou; Theodora Pappa; Gregory Kaltsas; Aggeliki Gouli; Kostas Mitsakis; Panayiotis Tsounas; Anastasia Prevoli; Vaios Tsiavos; Labrini Papanastasiou; George Zografos; George P Chrousos; George P Piaditis
Journal:  J Clin Endocrinol Metab       Date:  2013-03-07       Impact factor: 5.958

7.  Association Between Pituitary-Adrenal Axis Dominance Over the Renin-Angiotensin-Aldosterone System and Hypertension.

Authors:  Makoto Daimon; Aya Kamba; Hiroshi Murakami; Kazuhisa Takahashi; Hideyuki Otaka; Koushi Makita; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Takeshi Nigawara; Kaori Sawada; Ippei Takahashi; Shigeyuki Nakaji
Journal:  J Clin Endocrinol Metab       Date:  2016-01-05       Impact factor: 5.958

8.  Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism.

Authors:  H M Siragy; W V Vieweg; S Pincus; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

9.  Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism.

Authors:  Rene Baudrand; Francisco J Guarda; Jasmine Torrey; Gordon Williams; Anand Vaidya
Journal:  J Clin Endocrinol Metab       Date:  2016-07-18       Impact factor: 5.958

Review 10.  Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.

Authors:  Nada El Ghorayeb; Isabelle Bourdeau; André Lacroix
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-27       Impact factor: 5.555

View more
  7 in total

Review 1.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

2.  Recalibrating Interpretations of Aldosterone Assays Across the Physiologic Range: Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry Measurements Under Multiple Controlled Conditions.

Authors:  Jenifer M Brown; Richard J Auchus; Brooke Honzel; James M Luther; Nicholas Yozamp; Anand Vaidya
Journal:  J Endocr Soc       Date:  2022-03-23

Review 3.  The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism.

Authors:  Piotr Jędrusik; Bartosz Symonides; Jacek Lewandowski; Zbigniew Gaciong
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

4.  Does the Aldosterone: Renin Ratio Predict Future Blood Pressure in Young Adults?

Authors:  Robert M Carey
Journal:  Hypertension       Date:  2021-07-07       Impact factor: 9.897

Review 5.  New findings bearing on the prevention, detection and management of high blood pressure.

Authors:  Robert M Carey; Paul K Whelton
Journal:  Curr Opin Cardiol       Date:  2021-07-01       Impact factor: 2.108

6.  Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement.

Authors:  Fabrizio Buffolo; Elisa Sconfienza; Jacopo Burrello; Isabel Losano; Giulio Mengozzi; Gabriella Priolo; Valeria Avataneo; Antonio D'Avolio; Franco Veglio; Franco Rabbia; Paolo Mulatero; Silvia Monticone
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

7.  Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism.

Authors:  Fumika Ochiai-Homma; Emiko Kuribayashi-Okuma; Yuya Tsurutani; Kenichi Ishizawa; Wataru Fujii; Kohei Odajima; Mika Kawagoe; Yoshihiro Tomomitsu; Masataka Murakawa; Shinichiro Asakawa; Daigoro Hirohama; Michito Nagura; Shigeyuki Arai; Osamu Yamazaki; Yoshifuru Tamura; Yoshihide Fujigaki; Tetsuo Nishikawa; Shigeru Shibata
Journal:  Hypertens Res       Date:  2021-07-29       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.